Skip to content

Clinical trials

Esophageal Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Country / region: Australia Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20161
20174
20181
20194
20204
20213
20224
20234
20248
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11
Completed9
Active, not recruiting8
Terminated7
Not yet recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Launceston General Hospital2
OncoC4, Inc.2
Pfizer2
Actym Therapeutics, Inc.1
Amgen1
Aminex Therapeutics, Inc.1
Arcus Biosciences, Inc.1
AstraZeneca1
Australasian Gastro-Intestinal Trials Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms39
Stomach Neoplasms23
Ovarian Neoplasms17
Colorectal Neoplasms16
Carcinoma, Non-Small-Cell Lung14
Pancreatic Neoplasms14
Uterine Cervical Neoplasms14
Urinary Bladder Neoplasms13
Breast Neoplasms11
Head and Neck Neoplasms10

Trials

Showing 76 to 39 of 39. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.